Work

Abstract 5421: Determining the benefit of comprehensive molecular testing in advanced cancers: BostonGene and Exigent Genomic INsight (BEGIN) study.

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-5421

Authors: Sibel Blau, Katherine Sanchez, Eric Schaefer, Julio A. Peguero, Paul Zito, Dheeraj Kodali, Artem Tarasov, Rheanna Carter, Kayla Hendricks, Anna Love, Lile Kontselidze, Polina Turova, Viktor Smirnov, Anna Ogloblina, Konstantin Rumyantsev, Neeharika Makani, Alexander Bagaev, Nathan Fowler

Institutions: Northwest Medical Specialties, New Mexico Cancer Center, Highlands Oncology Group, Oklahoma Cancer Specialists and Research Institute

Language: English

Topic: Cancer Genomics and Diagnostics

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148664641

Cites:

Cited by:

Related to: